These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30552176)

  • 1. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.
    Kloppenburg M; Peterfy C; Haugen IK; Kroon F; Chen S; Wang L; Liu W; Levy G; Fleischmann RM; Berenbaum F; van der Heijde D; Bansal P; Wittoek R; Feng S; Fang Y; Saltarelli M; Medema JK; Levesque MC
    Ann Rheum Dis; 2019 Mar; 78(3):413-420. PubMed ID: 30552176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.
    Fleischmann RM; Bliddal H; Blanco FJ; Schnitzer TJ; Peterfy C; Chen S; Wang L; Feng S; Conaghan PG; Berenbaum F; Pelletier JP; Martel-Pelletier J; Vaeterlein O; Kaeley GS; Liu W; Kosloski MP; Levy G; Zhang L; Medema JK; Levesque MC
    Arthritis Rheumatol; 2019 Jul; 71(7):1056-1069. PubMed ID: 30653843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Lutikizumab, an Anti-Interleukin-1
    Cao Z; Li Y; Wang W; Jie S; Hu X; Zhou J; Wu T; Aili D; Long Z; Li Y; Dou P; Wu R
    Biomed Res Int; 2020; 2020():9013283. PubMed ID: 33204726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study.
    Wang SX; Abramson SB; Attur M; Karsdal MA; Preston RA; Lozada CJ; Kosloski MP; Hong F; Jiang P; Saltarelli MJ; Hendrickson BA; Medema JK
    Osteoarthritis Cartilage; 2017 Dec; 25(12):1952-1961. PubMed ID: 28964890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.
    Aitken D; Laslett LL; Pan F; Haugen IK; Otahal P; Bellamy N; Bird P; Jones G
    Osteoarthritis Cartilage; 2018 Jul; 26(7):880-887. PubMed ID: 29499287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Tolerability of a Dual Variable Domain Immunoglobulin ABT-981 Against IL-1α and IL-1β in Healthy Subjects and Patients With Osteoarthritis of the Knee.
    Kosloski MP; Goss S; Wang SX; Liu J; Loebbert R; Medema JK; Liu W; Dutta S
    J Clin Pharmacol; 2016 Dec; 56(12):1582-1590. PubMed ID: 27150261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
    Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
    Trials; 2014 Oct; 15():412. PubMed ID: 25348033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis.
    Kvien TK; Fjeld E; Slatkowsky-Christensen B; Nichols M; Zhang Y; Prøven A; Mikkelsen K; Palm Ø; Borisy AA; Lessem J
    Ann Rheum Dis; 2008 Jul; 67(7):942-8. PubMed ID: 17962237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH).
    Davis CR; Ruediger CD; Dyer KA; Lester S; Graf SW; Kroon FPB; Whittle SL; Hill CL
    Osteoarthritis Cartilage; 2021 Feb; 29(2):208-214. PubMed ID: 33232804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of erosive joints is a strong predictor of radiological progression in hand osteoarthritis: results of a 2-year prospective follow-up of the Liège Hand Osteoarthritis Cohort (LIHOC).
    Neuprez A; Kaux JF; Locquet M; Beaudart C; Reginster JY
    Arthritis Res Ther; 2021 Jan; 23(1):12. PubMed ID: 33407767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation and antibodies to citrullinated peptides in hand osteoarthritis.
    Dolzani P; Assirelli E; Pulsatelli L; Addimanda O; Mancarella L; Peri G; Mantovani A; Facchini A; Meliconi R
    Clin Exp Rheumatol; 2011; 29(6):1006-9. PubMed ID: 22032420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial.
    Altman RD; Dreiser RL; Fisher CL; Chase WF; Dreher DS; Zacher J
    J Rheumatol; 2009 Sep; 36(9):1991-9. PubMed ID: 19648310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial.
    Ferrero S; Wittoek R; Allado E; Cruzel C; Fontas E; Breuil V; Ziegler L; Kremer J; Loeuille D; Roux CH
    Semin Arthritis Rheum; 2021 Aug; 51(4):831-838. PubMed ID: 34157578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation.
    van Delft MAM; van Beest S; Kloppenburg M; Trouw LA; Ioan-Facsinay A
    J Rheumatol; 2019 Jan; 46(1):101-105. PubMed ID: 30219766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial.
    Kroon FPB; Kortekaas MC; Boonen A; Böhringer S; Reijnierse M; Rosendaal FR; Riyazi N; Starmans M; Turkstra F; van Zeben J; Allaart CF; Kloppenburg M
    Lancet; 2019 Nov; 394(10213):1993-2001. PubMed ID: 31727410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.
    Kloppenburg M; Ramonda R; Bobacz K; Kwok WY; Elewaut D; Huizinga TWJ; Kroon FPB; Punzi L; Smolen JS; Vander Cruyssen B; Wolterbeek R; Verbruggen G; Wittoek R
    Ann Rheum Dis; 2018 Dec; 77(12):1757-1764. PubMed ID: 30282670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain.
    Kropáčková T; Šléglová O; Růžičková O; Vencovský J; Pavelka K; Šenolt L
    BMC Musculoskelet Disord; 2018 Jul; 19(1):264. PubMed ID: 30053814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Dakin P; DiMartino SJ; Gao H; Maloney J; Kivitz AJ; Schnitzer TJ; Stahl N; Yancopoulos GD; Geba GP
    Arthritis Rheumatol; 2019 Nov; 71(11):1824-1834. PubMed ID: 31207169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center.
    Gabay C; Medinger-Sadowski C; Gascon D; Kolo F; Finckh A
    Arthritis Rheum; 2011 Nov; 63(11):3383-91. PubMed ID: 21898340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
    Kedor C; Detert J; Rau R; Wassenberg S; Listing J; Klaus P; Braun T; Hermann W; Weiner SM; Buttgereit F; Burmester GR
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34215704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.